Number of investors
Capital raised YTD
Renoon, is the innovative first-to-market solution that allows consumers to search for sustainable garments from multiple sites simultaneously. The proprietary technology developed is capable of aggregating hundreds of thousands of products, offering a scalable solution. Renoon's mission is to accelerate the transition to a sustainable fashion industry.
Fiscal benefits on investment: ✔️
IAG - Italian Angels for Growth
PEP-Therapy is a medical biotechnology company that develops innovative peptides as targeted therapies for serious diseases, with an initial focus on cancer treatment. It has created a "Cell Penetrating &Interfering Peptide" (CP&IP) technology for the development of its therapeutic products.
PEP-Therapy deals with two aggressive diseases with high medical demands and poor prognosis: triple negative metastatic breast cancer and platinum-resistant ovarian cancer.
PEP-Therapy focuses on the product PEP-010 to quickly demonstrate the relevance of its innovative technology from a clinical point of view.
Brots has developed an app that allows artists to reach listeners who are looking for new music, eliminating all activities not strictly related to music, such as social networking and creating compelling content to capture the audience's attention.
Brots users discover new music by listening to a 30 second preview and evaluate it with a swipe. The proprietary algorithm analyzes users' tastes to suggest people nearby with the same musical tastes to interact with and events both digital and live that reflect their musical interests.
Fiscal benefits on investment:✔️
Garanteasy provides consumers with a cloud platform on which to store and manage warranties on purchased products for their entire life, warns them of product expirations and maintenance and allows them to request support in case of defects or damages. To make the storage and management of any type of warranty fully automatic, the Garanteasy platform interfaces with all actors involved in the warranty ecosystem: manufacturers, retailers, e-commerce, insurance, service centers and payment systems.
Fiscal benefits on investment: ️✔️
To see all opportunities become a member
How it works
Doorway selects with the Advisors the best innovative companies to invest in.
A team of experts verifies the team, the business model, and the company numbers to be funded.
Doorway proposes the selected investment to its community on the platform.
Doorway and investors monitor the evolution of the Company with the proprietary Financial dashboard.
Doorway selects only investment opportunities with real prospects for monetization.
Qapla' is positioned as the multi-track technology solution that allows eCommerce to automate the company's shipment management, while offering an innovative strategic marketing tool to acquire and retain new users, helping companies to significantly increase the number of shipments. A single dashboard through which the company can monitor and manage its shipments, issuing waybills, customizing tracking pages and activating specific marketing campaigns.
Qaplà addresses its value proposition to all companies that market physical products, both online (about 35,000 in Italy) and offline, using external couriers, and making more than 15 shipments per month. The business model is of the SAAS (software as a service)- B2B - Pay per Use type, offering customers the possibility to use the platform by purchasing credits to be spent only for the services used.
Deliveristo is the Italian food delivery platform dedicated to B2B.
Deliveristo offers an innovative service: it digitizes the current supplies of restaurateurs and chefs thanks to a platform that puts them in direct contact with producers in an easy, fast and efficient way, eliminating all intermediaries.
Deliveristo was founded in 2017 by Ivan Aimo and Luca Calia, two thirty-year-olds with a training halfway between physical engineering and business administration, who coordinate a group of young entrepreneurs and stratuppers who deal with the selection of producers, consultancy to restaurateurs, customer care that monitors the efficiency and punctuality of deliveries.
Just one year after the commercial launch, 300 producers have already joined (of which about thirty produce dairy products), for a total of about 8000 products and 300 chefs/restaurants who have purchased, generating a turnover with an average constant growth of 40% month on month from launch to date.
ACBC is an innovative start-up that designs and manufactures patented sustainable footwear. Founded in 2017 by two young Italians, Edoardo Iannuzzi and Gio Giacobbe, ACBC has immediately becaome global thanks to a video that has reached 50 million views and over 2,500 worldwide customers. So far ACBC holds 13 single brand stores in 9 countries and has co-branded partnerships with brands including Moschino and Armani.
Acbc has created a revolutionary concept of footwear, which allows the interchangeability of all models of soles and all models of uppers through a zipper. The technology is protected by a patent extended to all major world markets.
In addition to customising shoes, ACBC offers a perfect product for travelling without packaging space for footwear and offers clear advantages from eco-sustainability point of view. Indeed, by sharing the same sole for multiple shoes, there are obvious and significant savings in terms of emissions at the production stage.
The AorticLab system is part of the treatment of the pathology of the Aortic Valve caused by its degeneration by calcification of the valve flaps and is composed of two devices: the TAF-Filter anti-embolic and the TDD-Decalcification System (debridement).
The treatment of this pathology is still carried out through the traditional surgical method SAVR (Surgical Aortic Valve Replacement), although there is a fast and progressive replacement with a much less invasive procedure such as TAVI/TAVR (Transcatheter Aortic Valve Implantation/ Replacement) technique that, in addition to avoiding open surgery, is applicable on a wider base of patients.
- TAF-Transcatether Antiembolic Filter: it is a new generation technology. Based on very recent studies on patients with severe aortic stenosis treated with TAVI the use of anti-embolic filters (TAF) is increasingly recommended as their use leads to a reduction in the frequency of ischemic events and brain injuries.
- TDD-Transcatheter Debridement Device: is a potentially disruptive technology. It consists of a revolutionary conservative treatment that fits into a fast-growing context such as TAVI and complements and supports its applicability.
the Doorway online magazine
On the press
Doorway è la piattaforma sulla quale gli investitori, persone fisiche e società, possono sottoscrivere on line quote di partecipazione al capitale sociale di Start up e PMI, quale asset class alternativa del proprio portafoglio.
Una piattaforma tecnologica di equity crowdfunding online riservata a smart investor in aziende che vogliono crescere di fatturato e di valore.
Doorway, è una startup innovativa, attiva sul mercato dal 2019, ha uno scopo ben preciso: innovare l’industria della raccolta di capitale di rischio destinati a startup e PMI, tramite un’esclusiva piattaforma Fintech di equity investing on line.
Doorway, al momento è l’unica piattaforma italiana di crowdfunding con una donna nel ruolo di Ceo.